MERIT MEDICAL SYSTEMS INC
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.5B | $1.4B | $1.3B | $1.2B | $1.1B |
| Gross profit | $738.3M | $643.3M | $583.9M | $519.1M | $485.3M |
| Operating income | $184.7M | $155.7M | $123.9M | $87.6M | $60.9M |
| Operating expenses | $553.5M | $487.6M | $459.9M | $431.5M | $424.4M |
| Cost of revenue | $777.6M | $713.2M | $673.5M | $631.9M | $589.4M |
| Cash from operations | $297.4M | $220.8M | $145.2M | $114.3M | $147.2M |
| Capital expenditure | $81.7M | $35.1M | $34.3M | $45.0M | $27.9M |
| Free cash flow | $215.7M | $185.7M | $110.9M | $69.3M | $119.3M |
| Impairments | $0 | $0 | $270,000 | $2.2M | $4.3M |
| Total assets | $2.7B | $2.4B | $2.3B | $1.7B | $1.6B |
| Total liabilities | $1.1B | $1.0B | $1.1B | $519.6M | $608.5M |
| Total debt | $747.5M | $747.5M | $846.6M | $198.2M | $243.1M |
Shares outstanding 59.7M · Free float 94.8%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.